BamSEC and AlphaSense Join Forces
Learn More

Quince Therapeutics Inc.

NASDAQ: QNCX    
Share price (12/20/24): $1.78    
Market cap (12/20/24): $78.3 million
Search in Documents
Key Exhibits
External Links

Articles of Incorporation Filter

EX-3.1
from 8-K 5 pages Certificate of Designation of Rights, Preferences and Privileges of Series a Junior Participating Preferred Stock of Quince Therapeutics, Inc
12/34/56
EX-3.2
from 8-K 24 pages Quince Therapeutics, Inc. a Delaware Corporation Amended and Restated Bylaws Quince Therapeutics, Inc. a Delaware Corporation Amended and Restated Bylaws
12/34/56
EX-3.1
from 8-K 1 page Certificate of Amendment of Amended and Restated Certificate of Incorporation of Cortexyme, Inc
12/34/56
EX-3.2
from 8-K 24 pages Cortexyme, Inc. a Delaware Corporation Amended and Restated Bylaws (As Amended and Restated Effective May 13, 2019) Cortexyme, Inc. a Delaware Corporation Amended and Restated Bylaws
12/34/56
EX-3.1
from 8-K 7 pages Amended and Restated Certificate of Incorporation of Cortexyme, Inc
12/34/56
EX-3.4
from S-1/A 24 pages Cortexyme, Inc. a Delaware Corporation Amended and Restated Bylaws as Adopted on , 2019 (Effective as of , 2019) Cortexyme, Inc. a Delaware Corporation Amended and Restated Bylaws
12/34/56
EX-3.2
from S-1/A 7 pages Amended and Restated Certificate of Incorporation of Cortexyme, Inc
12/34/56
EX-3.1
from S-1/A 27 pages Amended and Restated Certificate of Incorporation of Cortexyme, Inc
12/34/56
EX-3.3
from S-1 22 pages Bylaws of Cortexyme, Inc
12/34/56
EX-3.1
from S-1 26 pages Amended and Restated Certificate of Incorporation of Cortexyme, Inc
12/34/56
EX-3.3
from DRS 22 pages Bylaws of Cortexyme, Inc
12/34/56
EX-3.1
from DRS 26 pages Amended and Restated Certificate of Incorporation of Cortexyme, Inc
12/34/56